4//SEC Filing
STARKS DANIEL J 4
Accession 0001104659-23-112618
CIK 0000001800other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:58 PM ET
Size
8.0 KB
Accession
0001104659-23-112618
Insider Transaction Report
Form 4
STARKS DANIEL J
Director
Transactions
- Sale
Common shares without par value
2023-10-26$93.81/sh−26,907$2,524,256→ 6,748,409 total - Sale
Common shares without par value
2023-10-26$94.33/sh−23,093$2,178,270→ 6,725,316 total
Holdings
- 258(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.06 to $94.05, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.06 to $94.72, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0000902132
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 4:58 PM ET
- Size
- 8.0 KB